Shionogi, a leading Japanese pharmaceutical company, has joined the CMAC consortium, marking a pivotal step in global collaboration and innovation. Renowned for addressing unmet medical needs, Shionogi brings valuable regulatory insights and deep scientific expertise to CMAC’s international network.
Read MoreA new £1m research project to realise the transformative potential of digital technologies like artificial intelligence (AI) in medicines development and manufacturing has been announced.
The Centre of Excellence in Regulatory Science and Innovation (CERSI) project aims to advance regulatory processes by integrating cutting-edge digital technologies.
Read MoreThis collaboration marks a significant milestone for the Centre in driving collaborative research and innovation within advanced pharmaceutical manufacturing.
Read More